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Abstract
Background: Transient Neonatal Diabetes Mellitus is the commonest cause of diabetes presenting in the first week
of life. Majority of infants recover by 3 months of age but are predisposed to developing type 2 diabetes later on in
life. This condition is usually due to genetic aberrations at the 6q24 gene locus, and can be sporadic or inherited.
This disorder has three phases: neonatal diabetes, apparent remission, relapse of diabetes.
Case Presentation: Our case, a neonate presented with low birth weight and growth retardation along with the
metabolic profile consistent with transient diabetes mellitus at birth. We report a novel clinical observation of
recurrent asymptomatic hypoglycaemia detected on pre-feed blood glucose level monitoring in our case with
transient neonatal diabetes mellitus at 6 weeks of age, 4 weeks after the remission of diabetes mellitus.
Conclusion: This case demonstrates that neonates in remission following transient diabetes mellitus can present with
recurrent asymptomatic hypoglycaemia without any other obvious congenital malformations seen. This asymptomatic
hypoglycaemia may persist for weeks and may be missed if pre-feed blood glucose level monitoring is not done in
these infants. Also, these infants may require an aggressive enteral feeding regimen with high glucose delivery rate to
maintain normoglycemia.
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Background
Transient Neonatal Diabetes Mellitus (TNDM) is a rare
genetic form of diabetes with incidence between
1:400,000 and 1:500,000 [1]. TNDM presents in the neo-
natal period requiring insulin treatment, remits by
18 months of age (median 3 months) and may relapse in
later childhood or adolesence [2, 3]. This condition can
be sporadic or inherited, with 70 % of the cases due to
defects at TNDM locus on chromosome 6q24 [1, 2].
We report a case of TNDM due to a de novo 6q24
duplication arising on paternally derived chromosome
who developed recurrent asymptomatic hypoglycaemia
during the remission phase.
Case presentation
Our case was a male infant, conceived by in-vitro fertil-
isation with donor sperm, born at 37 weeks gestation
with a birth weight of 2125 gms(5th percentile), length
44.5cms (5th percentile) and head circumference
30.5cms (1st percentile). He was delivered via caesarean
section due to intrauterine growth restriction (IUGR)
suspected in the last trimester of pregnancy. There was
no maternal history of gestational diabetes or hyperten-
sion and maternal infection serology was negative. The
infant was noted to have mild pitting oedema of lower
limbs, extending up to the umbilicus, which spontan-
eously resolved by day 3 of life. He also had mild macro-
glossia. There was no family history of diabetes apart
from the history that his maternal grandmother devel-
oped Type 2 Diabetes in her 80s.
Formula feeds (upon parental request) were com-
menced soon after birth at 60 ml/kg/day and were given
as third hourly bolus feeds. At 10 h of age, the infant
was detected to have hyperglycaemia with blood glucose
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level (BGL) of 18 mmol/L on routine pre-feed monitor-
ing performed for intrauterine growth restriction, as per
unit policy. Subsequent pre-feed BGL remained consist-
ently high (8.0–15.6 mmol/L) over the next 12 h with
glycosuria but no ketonuria. This was managed with
diluted formula feeds (¼ strength) given as hourly bolus
feeds, with rapid resolution of hyperglycaemia and no
insulin treatment was required. On day 3 of life full
strength formula feeds were re-introduced gradually
increasing to 150 ml/kg/day as 3rd hourly sucking feeds.
However, on day 7 of life, there was a relapse of hyper-
glycaemia (BGL 19 mmol/L) associated with poor feed-
ing, weight loss of 14.8 % since birth, and non-bilious
vomiting. This was managed with intravenous insulin
infusion 0.02 U/kg/hr with continous tube feeds of
standard term infant formula (20 kcal/30 mL). Insulin
levels measured at the time of hyperglycemia (BGL
11.3 mmol/L) and before insulin treatment were un-
detectable (<2 mU/L), with low C peptide level of
0.1 nmol/L, beta-hydroxybutyrate 0.09 mmol/L and free
fatty acids 0.11 mmol/L. His Thyroid function tests were
normal. Blood Autoantibody testing against insulin,
Tyrosine phosphatase-related islet antigen 2 (IA2) and
glutamic acid decarboxylase (GAD) were all negative.
Ultrasound revealed structurally normal pancreas and
kidneys. On day 11 of life, normal term infant formula
was changed to fully hydrolysed amino acid formula
(Neocate-LCP, Nutricia) due to blood in stools, clinically
consistent with cow’s milk protein colitis. There was a
clinical response detected to this change with no further
blood in stools.
From day 12 of life, the insulin infusion was grad-
ually weaned and ceased by day 19 with stable BGLs
of 4–6 mmol/L. Third hourly formula feeds (20 kcal/
30 mL) via gastric tube were again established with
regular BGL monitoring.
On day 44 of life, hypoglycemia (BGL 2.1 mmol/L)
was detected on routine capillary pre-feed sugar moni-
toring. The infant at that point was on 170 ml/kg/day of
3rd hourly formula tube feeds with an estimated glucose
delivery rate (GDR) of 8.5 mg/kg/min and energy density
of 20 kcal/30 mL. Further pre-feed glucose monitoring
revealed recurrent asymptomatic hypoglycaemic epi-
sodes (BGL ranging 2.0–2.5 mmol/L). Critical blood
sample collected at the time of hypoglycaemia (BGL
2.4 mmol/L) showed no evidence of hyperinsulinism, an
appropriately suppressed insulin level (<2 mU/L), and
detectable beta-hydroxybutyrate (0.19 mmol/L) levels.
There was no response to Glucagon injection when tried
to treat a random episode of hypoglycaemia (BGL
2 mmol/L), but resolved after increasing the energy
density in the formula suggesting substrate deficiency as
the cause. Of note, the baby’s weight standard deviation
score had decreased from −2.17 at birth to −2.66. The
energy density of the formula 20 kcal/30 mL was in-
creased by adding glucose polymer (Polyjoule, Nutricia)
(2 kcal/30 mL) to fortify it to 22 kcal/30 mL. This in-
creased the glucose content of the milk to 8.7 % to give
GDR of 10.3 mg/kg/min with 128 kcal/kg/day. The for-
mula was then concentrated to 22 kcal/30 ml to make the
total energy density 24 kcal/30 ml. This increased the glu-
cose content to 9.6 % to give GDR to 11 mg/kg/min at
165 ml/kg/day with 130 kcal/kg and was required to
maintain normoglycemia. The formula was concentrated
to maintain the protein to energy ratio to allow adequate
energy for growth secondary to IUGR. The increased fat
and protein intake by concentrating the formula was
intended to reduce the glycemic load rather than just add
extra glucose. The carbohydrate in the Neocate-LCP is
dried glucose syrup that has a high glycemic index.
The infant was discharged home on third hourly naso-
gastric tube feeds at 24 kcal/30 mL, at 170 ml/kg/day.
Two oral feeds per day were allowed under the guidance
of a speech pathologist. Parents were trained to perform
pre-feed BGL at home and were educated to treat
emergency hypoglycaemia at home with a glucose
polymer solution (33 % concentration) to provide one
hour’s worth of glucose administered as a bolus via
nasogastric tube.
At 14 months of age, there was no further
hypoglycaemia and his weight standard deviation score
had improved to −0.32. The infant underwent a moni-
tored fasting study for 12 h. At the end of the 12-h fast
the BGL remained normal (3.3 mmol/L), with appropri-
ately elevated beta-hydroxybutyrate (1.49 mmol/L) and
free fatty acids (0.73 mmol/L). The following day the
baby developed adenovirus gastroenteritis and was
readmitted to hospital with hypoglycaemia, indicating
a tendency to ketotic hypoglycaemia during intercur-
rent illness.
Genetic DNA testing for neonatal diabetes revealed no
pathogenic mutation in common KCNJ11, ABCC8 and
INS genes. Mutations in these genes is the most com-
mon cause of permanent neonatal diabetes [1]. Methyla-
tion specific PCR of the infant’s DNA and microsatellite
analysis on the infant and mother’s DNA at several
markers within the TNDM critical region were performed.
This revealed presence of partial hypo-methylation at the
TNDM locus and increased paternal allele dosage in the
patient, suggestive of paternal duplication of 6q24 locus.
Subsequent analysis of paternal blood-derived DNA
showed no evidence of duplication, suggesting that this
duplication probably arose de-novo.
Case discussion
Our infant presented with low birth weight and growth
retardation along with the metabolic profile consistent
with transient diabetes mellitus. The growth retardation
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is consistent with the finding with those with abnormal-
ity of the 6q24 gene locus for TNDM [1, 4] and is likely
related to the failure of insulin secretion, which is a
potent growth factor in fetal life [1].
Our infant, growth restricted at birth developed asymp-
tomatic hypoglycaemia at 6 weeks of age with no evidence
of hyperinsulism. His declining weight Standard deviation
score and response to increased feed intake suggests sub-
strate deficiency as the cause of his hypoglycaemic epi-
sodes. These hypoglycaemic episodes did not respond to
glucagon treatment and diazoxide therapy was not tried as
there was no evidence of hyperinsulism.
Asymptomatic hypoglycaemia as noted in our case is a
very rare observation in this rare syndrome. We compare
our case with the previous 6 cases reported by Flanagan
et al. [4]. Flanagan’s report quoted 14 % incidence of
hypoglycaemia in their cohort (6 out of 43 cases), all of
which were symptomatic. The mean age of onset of symp-
tomatic hypoglycaemia in their cases was 29 weeks. Five
of their 6 cases had TNDM due to paternal uniparental
disomy; of these 3 had hyperinsulinism (detectable insulin
levels at the time of hypoglycaemia) and 2 had probable
hyperinsulinism (undetectable insulin levels, but sup-
pressed ketones at the time of hypoglycaemia, and
zresponse to diazoxide therapy. The remaining case had a
paternal duplication similar to our patient, but neither
insulin nor ketones were measured at the time of
hypoglycaemia. This case also had only short-lived epi-
sodes of hypoglycaemia with intercurrent illness (similar
to our patient) whereas the other 5 had ongoing problems
for 2 or more years (4 requiring diazoxide therapy and the
other requiring continuous overnight feeds).
The genetic cause of transient neonatal diabetes melli-
tus has been attributed to overexpression of imprinted
and paternally expressed gene/s within the TNDM crit-
ical region at 6q24 chromosome [4]. Two imprinted
genes, ZAC(zinc finger protein associated with apoptosis
and cell cycle arrest) and HYMAI (imprinted in hydatidi-
form mole) have been identified as potential candidates
[1]. Three genetic mechanisms have been shown to
result in TNDM: paternal uniparental isodisomy of
chromosome 6, paternally inherited duplication of 6q24,
and a methylation defect at a CpG island overlapping
exon 1of PLAGL1/HYMAI [4]. Our case was detected to
have a partial hypomethylation at the TNDM locus of
6q24 and also had additional paternal allele dosage
detected on the 6q24 gene. Thus, in view of the absence
of a significant methylation defect, the abnormality in
our patient was attributed to the duplication of paternal
6q24 gene, resulting in TNDM.
With regards to timing of BGL monitoring, hypoglycemia
in our infant was detected on pre-feed sugar monitoring
while on 170 ml/kg/day of 3rd hourly enteral feeds. Post-
feed BGL following these hypoglycaemic episodes were
always normal. Pre-feed detection of low BGL resulted in
early detection of hypoglycemia. There is no study that
looks specifically at the optimal timing and intervals for
glucose screening. Our case demonstrates that the brief
period of asymptomatic recurrent hypoglycaemia would
have been likely missed, if only post feed BGLs were
monitored.
Animal model studies have shown an increase in the
number of pancreatic beta cells prior to diabetes remis-
sion and it is possible that in some patients there is an
‘overshoot’ of this process and consequently beta cell
hyperplasia [5], however our patient had undetectable
insulin during the episode of hypoglycemia.
Conclusion
Thus, it is important to be aware of the risk of
hypoglycemia in early days of life following remission of
diabetes mellitus in patients with 6q24 chromosome de-
fect. We suggest regular pre-feed BGL monitoring in
these infants to identify subclinical hypoglycaemia which
may not be noticed on post-feed BGL monitoring alone.
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